Dabrafenib

ATC L01EC02 · 10 markets · 32 records

Dabrafenib 10 markets · 32 records Forms

US 4 records · 3 strengths

75 mgcapsuleTafinlar also in GB·CN·CA +4
50 mgcapsuleTafinlar also in GB·CN·CA +4
10 mgtabletTafinlar+1__no_trade__ also in GB·CA·AU +2

GB 4 records · 3 strengths

75 mgcapsuleTafinlar also in US·CN·CA +4
50 mgcapsuleTafinlar also in US·CN·CA +4
10 mgtabletFinlee 10mg dispersible tablets also in US·CA·AU +2

CN 4 records · 2 strengths

75 mgcapsule泰菲乐甲磺酸达拉非尼 also in US·GB·CA +4
50 mgcapsule泰菲乐甲磺酸达拉非尼 also in US·GB·CA +4

HK 4 records · 1 strengths

Records without a stated strength · 1 Tafinlar

CA 3 records · 3 strengths

75 mgcapsuleTafinlar also in US·GB·CN +4
50 mgcapsuleTafinlar also in US·GB·CN +4
10 mgtabletTafinlar also in US·GB·AU +2

AU 3 records · 3 strengths

75 mgcapsuleTafinlar also in US·GB·CN +4
50 mgcapsuleTafinlar also in US·GB·CN +4
10 mgtabletTafinlar also in US·GB·CA +2

SG 3 records · 3 strengths

75 mgcapsuleTAFINLAR HARD CAPSULE 50MG also in US·GB·CN +4
50 mgcapsuleTAFINLAR HARD CAPSULE 50MG also in US·GB·CN +4
10 mgtabletTafinlar also in US·GB·CA +2

ES 3 records · 3 strengths

75 mgcapsuleTafinlar also in US·GB·CN +4
50 mgcapsuleTafinlar also in US·GB·CN +4
10 mgtabletFINLEE DISPERSABLES also in US·GB·CA +2

TW 2 records · 2 strengths

75 mgcapsuleTafinlar+1泰伏樂膠囊75毫克 also in US·GB·CN +4
50 mgcapsuleTafinlar+1泰伏樂膠囊50毫克 also in US·GB·CN +4

EU 2 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Finlee 10mg dispersible tablets、Tafinlar

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	CN	ES	TW	HK	EU
75 mg capsule	Tafinlar	Tafinlar	Tafinlar	Tafinlar	TAFINLAR HARD CAPSULE 50MG	泰菲乐甲磺酸达拉非尼	Tafinlar	Tafinlar 泰伏樂膠囊75毫克	not recorded	not recorded
50 mg capsule	Tafinlar	Tafinlar	Tafinlar	Tafinlar	TAFINLAR HARD CAPSULE 50MG	泰菲乐甲磺酸达拉非尼	Tafinlar	Tafinlar 泰伏樂膠囊50毫克	not recorded	not recorded
10 mg tablet	No trade name Tafinlar	Finlee 10mg dispersible tablets	Tafinlar	Tafinlar	Tafinlar	not recorded	FINLEE DISPERSABLES	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Tafinlar	Finlee 10mg dispersible tablets Tafinlar

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in HK · EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en HK · EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 HK · EU 有记录（未在本表显示）。另有 1 個規格/劑型僅在 HK · EU 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

Also called: 达拉菲尼 nickname

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.